Anticorps Recombinant de lapin anti-JAM3
JAM3 Recombinant Antibody for FC
Hôte / Isotype
Lapin / IgG
Réactivité testée
souris
Applications
FC
Conjugaison
Non conjugué
CloneNo.
242630E6
N° de cat : 98393-2-RR
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en cytométrie | Transfected HEK-293T cells, |
Dilution recommandée
| Application | Dilution |
|---|---|
| This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Informations sur le produit
98393-2-RR cible JAM3 dans les applications de FC et montre une réactivité avec des échantillons souris
| Réactivité | souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | JAM3 Protéine recombinante Eg2661 |
| Nom complet | junction adhesion molecule 3 |
| Masse moléculaire calculée | 35 kDa |
| Numéro d’acquisition GenBank | NM_023277.4 |
| Symbole du gène | Jam3 |
| Identification du gène (NCBI) | 83964 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS with 0.09% sodium azide |
| Conditions de stockage | Store at 2 - 8°C. Stable for one year after shipment. |
Informations générales
Junctional adhesion molecule 3 (JAM3) is a type I transmembrane glycoprotein containing two Ig-like domains, which is expressed in various tissues and plays a crucial role in cell junctions, cell polarity, and motility (PMID: 34292449; 28931565). It has been proposed that JAM3 participates in leukocyte-platelet interactions, as well as angiogenesis and brain development (PMID: 12208882; 23255084). JAM3 may also be a new marker for predicting the prognosis and immune functions of bladder cancer patients (PMID: 38400838).
Protocole
| Product Specific Protocols | |
|---|---|
| FC protocol for JAM3 antibody 98393-2-RR | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |

